Falk W, Leonard E J
Infect Immun. 1980 Sep;29(3):953-9. doi: 10.1128/iai.29.3.953-959.1980.
Only 20 to 40% of human blood monocytes were capable of responding to chemotaxins in vitro. This limit is not due to restrictions of the in vitro system, but is due to the existence of a migrating subpopulation. Over a wide range, the number of cells migrating toward a given concentration of chemotaxin was directly proportional to the number added to the chemotaxis chamber. These monocytes responded to all of the three stimuli used: human serum-derived C5a, human lymphocyte-derived chemotactic factor, and a synthetic peptide. It was possible to deactivate cells to one attractant, leaving the response to other attractants intact. This suggested that these attractants were recognized by different receptors. Several lines of evidence showed that most migrating cells had receptors for all three chemotaxins tested. Thus, if cells were assayed for migration to one attractant, no additional migration occurred when the remaining cells were assayed for migration to a different attractant. Furthermore, the same cells that had migrated toward one attractant were able to respond to other chemotaxins. We also found that a single attractant attracted as many cells as a combination of two or three attractants. Calculations from these data showed that at least 75% of the migrating monocytes have different receptors for all three attractants.
体外培养时,只有20%至40%的人体血液单核细胞能够对趋化因子作出反应。这一限制并非源于体外培养系统的局限性,而是由于存在一个迁移亚群。在很大范围内,向特定浓度趋化因子迁移的细胞数量与加入趋化室的细胞数量成正比。这些单核细胞对所使用的三种刺激物均有反应:人血清来源的C5a、人淋巴细胞来源的趋化因子以及一种合成肽。有可能使细胞对一种吸引剂失去活性,而对其他吸引剂的反应保持不变。这表明这些吸引剂是由不同的受体识别的。多项证据表明,大多数迁移细胞对所测试的所有三种趋化因子都有受体。因此,如果检测细胞对一种吸引剂的迁移情况,当检测剩余细胞对另一种不同吸引剂的迁移时,不会发生额外的迁移。此外,向一种吸引剂迁移的相同细胞能够对其他趋化因子作出反应。我们还发现,单一吸引剂吸引的细胞数量与两种或三种吸引剂组合吸引的细胞数量相同。根据这些数据计算表明,至少75%的迁移单核细胞对所有三种吸引剂都有不同的受体。